New thesis paves the way for oral delivery of peptide therapeutics

Shahina Akter ny avhandling

In a new SweDeliver thesis, PhD Student Shahina Akter shows how sodium caprate – an important excipient for the oral delivery of peptide drugs – behaves in the intestinal environment. Welcome to her public defence on Friday 18 September at Uppsala Biomedical Centre.

As part of a research project at the SweDeliver research centre, Shahina Akter, a PhD student at the Department of Pharmacy, has investigated how the excipient sodium caprate (C10) can be used for the oral delivery of peptide drugs.

Per Larsson, handledare

Per Larsson leder SweDelivers arbetspaket Oral läkemedelstillförsel

The high selectivity of peptide drugs makes them important in the treatment of many diseases including diabetes. However, peptides also present scientific challenges, including their often very low bioavailability when administered orally. The addition of excipients can enhance a drug's ability to cross the intestinal wall.

“One such excipient is C10, but because it forms different structures depending on its surrounding environment, we need to increase our understanding of how C10 behaves in the intestinal environment. In my thesis, I have used computer simulations and advanced measurement techniques to study how the substances surrounding C10 affect its aggregation,” says Shahina Akter.

Shahina's results show that lower pH can cause C10 to form larger and more complex aggregates. The study also shows that C10 interacts with components of intestinal fluid, and that the addition of peptides affects the C10 structures that form. In a third study, Akter shows that adding the positively charged polymer poly-L-lysine further alters the self-assembly.

“By combining computer simulations with, among other techniques, small-angle X-ray scattering (SAXS), our results contribute new pieces to the puzzle of characterising the structures that form and to increasing our understanding of what happens at the molecular level. These results, in turn, add knowledge along the way towards oral formulations for peptide drugs”.

Shahina Akter was recruited as a PhD student to the SweDeliver Work Package Oral Drug Delivery in 2021. Recent reports on the centre’s operations emphasise its strong scientific position, with the Oral Drug Delivery Work Package – under the leadership of Per Larsson at the Department of Pharmacy – currently ranking among the world’s foremost.

“Throughout this time, I have actively participated in SweDeliver retreats, workshops, webinars, and other activities. These experiences have given me valuable opportunities to connect with industry partners and professionals, exchange ideas, and learn from others’ expertise. Being part of the SweDeliver community has enriched my doctoral experience and helped me build meaningful professional connections. I am grateful for its continued support and the opportunity to be part of such a collaborative and inspiring network,” says Shahina Akter.

Researcher bio:

Shahina Akter graduated in Pharmacy from Heinrich Heine University Duesseldorf (HHU) in Germany. She received her Master's degree in Industrial Pharmacy, focusing her master’s thesis on Molecular simulations of membrane permeability.

In early 2021, Shahina was recruited as a PhD student to SweDeliver and Uppsala University's research environment in Drug Delivery.

Facts

  • On Friday 18 September, Shahina Akter will defend her PhD thesis, Self-assembly of sodium caprate: colloidal architectures for oral peptide delivery, at Uppsala Biomedical Centre.
  • Her supervisor is Per Larsson, Senior Lecturer at the Department of Pharmacy. Her co-supervisors are Per Hansson and Magnus Bergström, Department of Medicinal Chemistry.
  • Opponent is Judith Kuntsche, Associate Professor at the University of Southern Denmark.

Contact

Shahina Akter, PhD Student
Department of Pharmacy • SweDeliver
Shahina.Akter@uu.se

text: Magnus Alsne, photo: Mikael Wallerstedt a o